Daré Bioscience Reports Q3 2024 Financial Results and Business Update

Daré Bioscience, Inc. (NASDAQ:DARE) held its Q3 2024 Earnings Conference Call on November 14, 2024. The call was led by company executives including Sabrina Martucci Johnson, President and CEO, and MarDee Haring-Layton, Chief Accounting Officer. The meeting aimed to discuss the financial results for the quarter ending September 30, 2024, and to provide an update on the company's business developments and pipeline expectations.

During the call, it was emphasized that the discussion would involve forward-looking statements as defined by federal securities laws. These statements are subject to risks and uncertainties, and actual outcomes may differ significantly from those projected. The company advised participants not to rely too heavily on these forward-looking statements, which are detailed in Daré's SEC filings, particularly the Form 10-Q filed for the quarter.

Daré Bioscience reiterated that the information shared in the call is time-sensitive and reflects the status as of November 14, 2024. The company does not commit to updating these statements after this date.